Stocks
Qiagen N.V.QGEN
NYSEHealthcareDiagnostics & Research$40.60-1.26%
Price as of · delayed, not real-time
A leading provider of sample and assay technologies for molecular diagnostics, applied testing, and pharmaceutical research. Investors track Qiagen for its critical role in life sciences workflows and its recurring revenue model tied to consumables.
Market Cap: $8.4B52W Range: $38.13 – $57.82
Congressional Interest in Qiagen N.V. (QGEN)
5 members of Congress have disclosed 19 trades in Qiagen N.V. (QGEN), a Healthcare company. The buy/sell breakdown shows 11 purchases versus 8 sales, indicating net buying interest from lawmakers. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Total Disclosures
19
Unique Politicians
5
Buys
11
Sells
8
Who in Congress Is Trading QGEN?
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2024-02-13 | Rohit Khanna | sell | $1K – $15K |
| 2020-03-24 | PETER WELCH | sell | $1K – $15K |
| 2020-02-27 | PETER WELCH | buy | $1K – $15K |
| 2019-10-08 | ALAN S. LOWENTHAL | sell | $737+ |
| 2019-10-08 | ALAN S. LOWENTHAL | sell | $1K – $15K |
| 2019-10-08 | ALAN S. LOWENTHAL | sell | $15K – $50K |
| 2019-09-13 | ALAN S. LOWENTHAL | buy | $1K – $15K |
| 2019-09-13 | ALAN S. LOWENTHAL | buy | $1K – $15K |
| 2019-09-13 | ALAN S. LOWENTHAL | buy | $135+ |
| 2019-09-12 | ALAN S. LOWENTHAL | buy | $168+ |
| 2019-09-12 | ALAN S. LOWENTHAL | buy | $1K – $15K |
| 2019-01-23 | Donna Shalala | sell | $1K – $15K |
| 2019-01-09 | Donna Shalala | sell | $1K – $15K |
| 2017-09-14 | JAMES B. RENACCI | buy | $15K – $50K |
| 2017-07-28 | JAMES B. RENACCI | buy | $15K – $50K |
| 2017-02-28 | ALAN S. LOWENTHAL | buy | $1K – $15K |
| 2015-10-23 | JAMES B. RENACCI | buy | $1K – $15K |
| 2011-08-11 | JAMES B. RENACCI | buy | $3,750.75 |
| 2011-08-11 | JAMES B. RENACCI | sell | $3,325.96 |